Patents Assigned to Hameln Pharma Plus GmbH
  • INTERMEDIATES FOR THE PREPARATION OF REMIFENTANIL HYDROCHLORIDE
    Publication number: 20200131127
    Abstract: A new intermediate for synthesizing 1-substituted-4-[phenyl(propanoyl)amino]piperidine-4-carbonitrile derivatives is laid open. Specifically set out is a method for use of this intermediate in the preparation of remifentanil. The enclosed shorter process offers a greater yield of products with higher purity as compared to methods reported in the prior art.
    Type: Application
    Filed: October 25, 2019
    Publication date: April 30, 2020
    Applicant: Hameln Pharma Plus GmbH
    Inventors: Pavol Valachovic, Janka Králová, Lubos Slízik, Norbert Varga
  • Crystalline forms of zinc trisodium pentetic acid
    Patent number: 9447120
    Abstract: The invention relates to the production of zinc trisodium pentetic acid (Zn-DTPA) and to new crystalline forms of said salt.
    Type: Grant
    Filed: May 23, 2014
    Date of Patent: September 20, 2016
    Assignee: Hameln Pharma Plus GmbH
    Inventors: Christian Schickaneder, Vendel Smahovský, Pavol Valachovic, Mathias Dewald, Pavel Hradil, Janka Králová, Radek Melnický, Petr Slézar, Ivan Kakalik